{"id":"NCT00306527","sponsor":"Novartis Vaccines","briefTitle":"Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in Adults and Elderly","officialTitle":"A Phase III, Observer-Blind, Randomized, Multi-Center Study to Evaluate Safety, Tolerability and Immunogenicity (in a Subset) Following a Single Intramuscular Dose of a Trivalent Subunit Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs, in Healthy Adult and Elderly Subjects Who Received Either One or the Other Vaccine One Year Before in the V58P4 Study.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-09","primaryCompletion":"2005-12","completion":"2006-04","firstPosted":"2006-03-24","resultsPosted":"2013-01-11","lastUpdate":"2019-08-14"},"enrollment":2235,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Cell culture derived influenza vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"egg-derived influenza subunit vaccine","otherNames":[]}],"arms":[{"label":"cTIV\\cTIV (adults)","type":"ACTIVE_COMPARATOR"},{"label":"cTIV\\TIV (adults)","type":"ACTIVE_COMPARATOR"},{"label":"cTIV\\cTIV (elderly)","type":"ACTIVE_COMPARATOR"},{"label":"cTIV\\TIV (elderly)","type":"ACTIVE_COMPARATOR"},{"label":"TIV\\TIV (adults)","type":"ACTIVE_COMPARATOR"},{"label":"TIV\\cTIV (adults)","type":"ACTIVE_COMPARATOR"},{"label":"TIV\\TIV (elderly)","type":"ACTIVE_COMPARATOR"},{"label":"TIV\\cTIV (elderly)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to evaluate safety, tolerability and immunogenicity (in a subset) following a dose of a trivalent subunit influenza vaccine produced either in mammalian cells or in embryonated hen eggs, in healthy adult and elderly subjects who received either vaccine one year before (2004) in the study V58P4.","primaryOutcome":{"measure":"Number of Subjects Reporting Solicited Adverse Events After One Dose of Cell Culture-derived or the Egg-derived Influenza Vaccine","timeFrame":"Day 1 to Day 7 postvaccination","effectByArm":[{"arm":"cTIV\\cTIV (Adults)","deltaMin":78,"sd":null},{"arm":"cTIV\\TIV (Adults)","deltaMin":73,"sd":null},{"arm":"cTIV\\cTIV (Elderly)","deltaMin":47,"sd":null},{"arm":"cTIV\\TIV (Elderly)","deltaMin":51,"sd":null},{"arm":"TIV\\TIV (Adults)","deltaMin":76,"sd":null},{"arm":"TIV\\cTIV (Adults)","deltaMin":84,"sd":null},{"arm":"TIV\\TIV (Elderly)","deltaMin":47,"sd":null},{"arm":"TIV\\cTIV (Elderly)","deltaMin":55,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":5,"countries":["Poland"]},"refs":{"pmids":["22418809"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":533},"commonTop":["Injection site pain","Injection site erythema","Malaise","Fatigue","Headache"]}}